The data point that matters most
At JCI-accredited Colombian hospitals, hospital-acquired infection rates run roughly 2.1–2.55 per 1,000 patient days, per Instituto Nacional de Salud data — comparable to US benchmark rates. That's the actual quality signal, and it has nothing to do with the procedure's price tag.
Where "cheap" genuinely does correlate with risk
The correlation that does hold: facilities operating far below the typical range for a given procedure, with no verifiable JCI or national accreditation, vague surgeon credentials, and no itemized quote, are a real risk category. That's a floor set by accreditation and verification — not by price relative to other accredited options.
How to separate the two
Check accreditation before comparing price
Verify JCI status or national-equivalent accreditation directly — this is the real quality gate.
Only compare prices within the accredited set
Once you've filtered to verified, accredited facilities, price differences reflect the structural factors covered in our cost-driver article — not quality gaps.
Treat an outlier-low quote as a red flag, not a deal
A quote significantly below the typical range for an accredited facility warrants extra scrutiny, not extra excitement.
The same accreditation-over-price logic applies whether you're evaluating a clinic through colombiabbl.co or colombiastemcelltreatment.com.
The Takeaway
Within the accredited tier, cheaper doesn't mean worse — it mostly reflects the structural cost factors covered elsewhere on this site. Outside that tier, all bets are off regardless of price.